Skip to content

Nasdaq · CIK 0001981535

SBET Sharplink, Inc.

Insider trading from SEC Form 4. Last filing 33 d ago. Close $8.59 on Oct 9, 2026, +88% from the 52-week low and -49% from the high.

Sharplink, Inc. (SBET) has 43 SEC Form 4 filings on file from 8 insiders, the latest filed on Sep 10, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

8 open-market trades have been scored at SBET. The newest: Leslie Bernhard (director) sold $96k of stock on May 12, 2026, filed May 15, 2026, scored 28 (weak). The largest of the 8 shown: Robert M Gutkowski (director) sold $352k on Aug 18, 2025, scored 55 (moderate). 2 insiders sold within 14 days of each other around May 12, 2026.

SBET closed at $8.59 on Oct 9, 2026, 88% above its 52-week low and 49% below its 52-week high.

4 Form 144 notices of planned sales are on file, the latest filed Dec 29, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company

Price and insider trades, last year

SBETOct 9, 2026 · close 8.59

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Sharplink, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
28WeakLeslie Bernhard
director
sell
$96k
12,892 shares
-34%+157% from low-91% from high
28WeakRobert M Gutkowski
director
sell
$95k
12,892 shares
-34%+157% from low-91% from high
22WeakRobert Michael DeLucia
Chief Financial Officer
sell
$18k
2,848 shares
-3%+156% from low-92% from high
55ModerateLeslie Bernhard
director
sell
$351k
18,334 shares
-42%-
55ModerateRobert M Gutkowski
director
sell
$352k
18,334 shares
-42%-
55ModerateObie McKenzie
director
sell
$351k
18,334 shares
-42%-
47ModerateRobert Michael DeLucia
Chief Financial Officer
buy
$50k
7,440 shares
+112%-
57ModerateRob Phythian
Chief Executive Officer
buy
$300k
44,640 shares
+351%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Dec 29, 2025 Rob Phythian
Former CEO
18,959
0.01% of outstanding
$171kDec 31, 2025none
Aug 18, 2025 Bernhard Leslie
Director
18,334
2.78% of outstanding
$364kAug 18, 2025none
Aug 18, 2025 GUTKOWSKI ROBERT M
Director
18,334
2.78% of outstanding
$364kAug 18, 2025none
Aug 18, 2025 MCKENZIE OBIE
Director
18,334
2.78% of outstanding
$364kAug 18, 2025none

Transactions

The newest 50 of 91 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 9, 2026Dana Eschenburg Perez
Chief Accounting Officer
FTax withholding
Common Stock
-2,841$8.54$24k63,61233 d ago
Sep 30, 2025Leslie Bernhard
director
MOption exercise
Common Stock
+1,389$0.00$026,387May 15, 2026
Sep 30, 2025Robert M Gutkowski
director
MOption exercise
Common Stock
+1,389$0.00$026,387May 15, 2026
Apr 10, 2026Robert M Gutkowski
director
AGrant or award
Common Stock
+11,503$6.52$75k37,890May 15, 2026
Apr 10, 2026Leslie Bernhard
director
AGrant or award
Common Stock
+11,503$6.52$75k37,890May 15, 2026
May 12, 2026Robert M Gutkowski
director
SOpen-market sale
Common Stock
-12,892$7.41$95k24,998May 15, 2026
May 12, 2026Leslie Bernhard
director
SOpen-market sale
Common Stock
-12,892$7.41$96k24,998May 15, 2026
Mar 31, 2026Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Common Stock
+10,904$0.00$095,946Mar 31, 2026
Mar 31, 2026Robert Michael DeLucia
Chief Financial Officer
SOpen-market sale
Common Stock
-2,848$6.21$18k93,098Mar 31, 2026
Feb 11, 2026Joseph Chalom
Chief Executive Officer
FTax withholding
Common Stock
-149,065$0.00$0142,764Feb 12, 2026
Feb 11, 2026Robert Michael DeLucia
Chief Financial Officer
FTax withholding
Common Stock
-22,863$0.00$085,042Feb 12, 2026
Jan 8, 2026Joseph Chalom
Chief Executive Officer
AGrant or award
Common Stock
+291,829$0.00$0291,829Jan 12, 2026
Jan 8, 2026Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Common Stock
+87,549$0.00$0107,906Jan 12, 2026
Aug 18, 2025Obie McKenzie
director
SOpen-market sale
Common Stock
-18,334$19.17$351k24,998Aug 18, 2025
Aug 18, 2025Leslie Bernhard
director
SOpen-market sale
Common Stock
-18,334$19.17$351k24,998Aug 18, 2025
Aug 18, 2025Robert M Gutkowski
director
SOpen-market sale
Common Stock
-18,334$19.17$352k24,998Aug 18, 2025
Jul 24, 2025Joseph Chalom
Co-Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+295,590--295,590Aug 4, 2025
Mar 19, 2025Rob Phythian
Co-Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+18,333--18,333Jul 29, 2025
Jul 24, 2025Leslie Bernhard
director
AGrant or award
Common Stock
+6,667--18,334Jul 29, 2025
Mar 19, 2025Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+10,904--10,904Jul 29, 2025
Jul 24, 2025Robert M Gutkowski
director
AGrant or award
Common Stock
+6,667--18,334Jul 29, 2025
Jul 24, 2025Obie McKenzie
director
AGrant or award
Common Stock
+6,667--18,334Jul 29, 2025
Jul 24, 2025Leslie Bernhard
director
AGrant or award
Common Stock
+24,998--43,332Jul 29, 2025
Jul 24, 2025Robert M Gutkowski
director
AGrant or award
Common Stock
+24,998--43,332Jul 29, 2025
May 26, 2025Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+112,493--112,493Jul 29, 2025
Jul 24, 2025Obie McKenzie
director
AGrant or award
Common Stock
+24,998--43,332Jul 29, 2025
May 26, 2025Rob Phythian
Co-Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+224,987--224,987Jul 29, 2025
Jul 24, 2025Leslie Bernhard
director
AGrant or award
Restricted Stock Unitsderivative
+6,667--6,667Jul 29, 2025
Jul 24, 2025Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+48,560--48,560Jul 29, 2025
Jul 24, 2025Robert M Gutkowski
director
AGrant or award
Restricted Stock Unitsderivative
+6,667--6,667Jul 29, 2025
Jul 24, 2025Obie McKenzie
director
AGrant or award
Restricted Stock Unitsderivative
+6,667--6,667Jul 29, 2025
Jul 24, 2025Rob Phythian
Co-Chief Executive Officer
AGrant or award
Restricted Stock Unitsderivative
+156,240--156,240Jul 29, 2025
Jul 24, 2025Leslie Bernhard
director
AGrant or award
Restricted Stock Unitsderivative
+74,996--74,996Jul 29, 2025
Jul 24, 2025Robert M Gutkowski
director
AGrant or award
Restricted Stock Unitsderivative
+74,996--74,996Jul 29, 2025
Jul 24, 2025Obie McKenzie
director
AGrant or award
Restricted Stock Unitsderivative
+74,996--74,996Jul 29, 2025
Jun 30, 2025Leslie Bernhard
director
AGrant or award
Common Stock
+5,556$0.00$011,667Jul 21, 2025
Jun 30, 2025Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Common Stock
+6,250$0.00$015,041Jul 21, 2025
Jun 30, 2025Robert M Gutkowski
director
AGrant or award
Common Stock
+5,556$0.00$011,667Jul 21, 2025
Jun 30, 2025Obie McKenzie
director
AGrant or award
Common Stock
+5,556$0.00$011,667Jul 21, 2025
Jun 30, 2025Rob Phythian
Chief Executive Officer
AGrant or award
Common Stock
+6,250$0.00$022,679Jul 21, 2025
Jun 30, 2025Leslie Bernhard
director
AGrant or award
Common Stock
+5,556$0.00$078,890Jul 3, 2025
Jun 30, 2025Robert Michael DeLucia
Chief Financial Officer
AGrant or award
Common Stock
+6,250$0.00$020,357Jul 3, 2025
Jun 30, 2025Robert M Gutkowski
director
AGrant or award
Common Stock
+5,556$0.00$078,890Jul 3, 2025
Jun 30, 2025Obie McKenzie
director
AGrant or award
Common Stock
+5,556$0.00$078,890Jul 3, 2025
Jun 30, 2025Rob Phythian
Chief Executive Officer
AGrant or award
Common Stock
+6,250$0.00$063,599Jul 3, 2025
May 30, 2025Joseph Michael Lubin
director
AGrant or award
Common Stockindirect: See Footnote
+180,000$6.15$1.1M180,000Jun 5, 2025
May 30, 2025Joseph Michael Lubin
director
AGrant or award
Common Stockindirect: See Footnote
+975,600$6.15$6.0M975,600Jun 5, 2025
May 30, 2025Joseph Michael Lubin
director
AGrant or award
Pre-Funded Warrantsderivative
+6,354,213$6.15$39M6,354,213Jun 5, 2025
May 30, 2025Joseph Michael Lubin
director
AGrant or award
Pre-Funded Warrantsderivativeindirect: See Footnote
+3,966,340$6.15$24M3,966,340Jun 5, 2025
May 30, 2025Joseph Michael Lubin
director
AGrant or award
Common Stock Purchase Warrantderivativeindirect: See Footnote
+691,004--691,004Jun 5, 2025
50 of 91 rows shown.

Insiders

Everyone who has filed a Form 4 here.

Questions about SBET

Answered from the filings on this page, as of the latest one.

Are insiders buying SBET?

No. In the last 90 days no insider at Sharplink, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade SBET on the open market?

Leslie Bernhard (director) sold $96k of SBET on May 12, 2026 and filed the Form 4 on May 15, 2026. InsiderTell scored 28 (weak), with 2 insiders on the same side within 14 days.

How many insiders file Form 4 at Sharplink, Inc.?

8 people have filed a Form 4 at Sharplink, Inc., among them Leslie Bernhard (director), Joseph Chalom (Chief Executive Officer), Robert Michael DeLucia (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.